bool(false)

Ivermectin sales in June surpass entire 2019 figures

. Aug 02, 2020
Ivermectin sales brazil

In June, the Brazilian pharmaceutical industry registered around 8.6 million sales of the medication Ivermectin, more than the total number of the drug sold in 2019 (8.2 million), according to data provided by the Industrial Pharmaceutical Union (Sindusfarma). The spike in sales in June represents a 1,222 percent increase in comparison to the same period in 2019, which recorded only 650,000 sales.

The medicine is normally used for the treatment of parasites, but is now associated with the treatment for Covid-19 in Brazil — despite the lack of evidence of its effectiveness in treating the coronavirus.

In June, the Brazilian pharmaceutical industry registered around 8.6 million sales of the medication Ivermectin, more than the total number of the drug sold in 2019 (8.2 million), according to data provided by the Industrial Pharmaceutical Union (Sindusfarma). The spike in sales in June represents a 1,222 percent increase in comparison to the same period in 2019, which recorded only 650,000 sales.

The medicine is normally used for the treatment of parasites, but is now associated with the treatment for Covid-19 in Brazil — despite the lack of evidence of its effectiveness in treating the coronavirus.

The drug has been widely distributed by city and state-wide administrations since the beginning of April, causing confusion among Brazilians as to whether they should use Ivermectin, even without clear evidence that it helps patients recover from Covid-19.Recently, The Brazilian Report covered the wave of Covid-19 “cure” drugs in Latin America spearheaded by another suspect drug, hydroxychloroquine, which has been widely touted by President Jair Bolsonaro

The drug has been widely distributed by city and state-wide administrations since the beginning of April, causing confusion among Brazilians as to whether they should use Ivermectin, even without clear evidence that it helps patients recover from Covid-19.

Recently, The Brazilian Report covered the wave of Covid-19 “cure” drugs in Latin America spearheaded by another suspect drug, hydroxychloroquine, which has been widely touted by President Jair Bolsonaro.

Support this coverage →Support this coverage →
 
Rafael Lima

Rafael is a Communication student at Wake Forest University, and a student fellow of the Pulitzer Center on Crisis Reporting.

Our content is protected by copyright. Want to republish The Brazilian Report? Email us at contact@brazilian.report